Skip to main content
MedPeer,Inc. logo

MedPeer,Inc. — Investor Relations & Filings

Ticker · 6095 ISIN · JP3921240002 LEI · 353800ORAK2PGV4HEZ88 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 65 across all filing types
Latest filing 2025-07-25 Legal Proceedings Report
Country JP Japan
Listing T 6095

About MedPeer,Inc.

https://medpeer.co.jp/

MedPeer, Inc. is a healthcare technology company operating under the mission "Supporting Doctors, Helping Patients." The company's business is structured around two main pillars: the Doctor Platform and the Healthcare Institution Support Platform. The core Doctor Platform business centers on "MedPeer," a collective intelligence community for physicians to share clinical knowledge and insights. This segment also offers career support services for medical professionals. The Healthcare Institution Support Platform provides solutions aimed at enhancing the operational efficiency of medical facilities, including clinics and pharmacies. By leveraging the collective expertise of healthcare professionals, MedPeer aims to reinvent healthcare.

Recent filings

Filing Released Lang Actions
訂正意見表明報告書
Legal Proceedings Report Classification · 1% confidence The document is a 'Declaration of Opinion Report' (意見表明報告書) regarding a Tender Offer (公開買付け) for MedPeer, Inc. It details the board's recommendation to shareholders, the background of the Management Buyout (MBO), and the subsequent squeeze-out procedures. This document is a formal regulatory filing required under the Financial Instruments and Exchange Act of Japan for tender offer responses. It is not an annual report, earnings release, or simple announcement, but a substantive legal filing detailing the board's position on a takeover bid.
2025-07-25 Japanese
訂正意見表明報告書
M&A Activity Classification · 1% confidence The document is titled "訂正意見表明報告書" (Correction Opinion Statement Report) and is filed with the Kanto Local Finance Bureau. The content explicitly discusses a tender offer (公開買付け - KOUKAI KAITSUKE) for the company's shares and stock acquisition rights, including details about the acquirer (NMT株式会社), the target company (メドピア株式会社), the offer price, the intent to take the company private (非公開化), and the recommendation from the target company's board regarding the tender offer. This structure and content are characteristic of documents filed under the Japanese Financial Instruments and Exchange Act concerning Tender Offers for Shares, specifically the 'Opinion Statement Report' (意見表明報告書) which is required to be filed by the target company in response to a tender offer. In the provided classification list, the closest and most appropriate category for a document detailing a takeover bid or merger proposal is 'M&A Activity' (Code: TAR). While it is a specific regulatory filing, TAR covers the M&A/Takeover context better than the general 'RNS' fallback.
2025-07-09 Japanese
訂正意見表明報告書
M&A Activity Classification · 1% confidence The document is titled "訂正意見表明報告書" (Correction Opinion Statement Report) and explicitly mentions the filing is made under the "発行者以外の者による株券等の公開買付けの開示に関する内閣府令 第四号様式" (Cabinet Office Ordinance on Disclosure of Tender Offer for Share Certificates, etc. by Persons Other Than the Issuer, Form No. 4). This form is used by the target company's board to state their opinion on a tender offer (takeover bid). The content details the tender offeror (NMT株式会社), the target company (メドピア株式会社), the proposed acquisition of shares and stock options, the board's resolution to recommend the tender offer, and extensive rationale related to M&A/takeover strategy (MBO, non-listing plans, subsequent squeeze-out procedures). This clearly identifies the document as related to a takeover bid/tender offer response, which falls under the category of M&A Activity (TAR). Although it is a 'Correction Report' (訂正), the underlying subject matter is the tender offer opinion.
2025-06-25 Japanese
意見表明報告書
M&A Activity Classification · 1% confidence The document is titled "意見表明報告書" (Opinion Statement Report) and is submitted to the Kanto Local Finance Bureau Director. It explicitly discusses a tender offer (公開買付け - Kōkai Kaitsuke) for MedPeer, Inc. shares and stock acquisition rights by NMT Corporation, which is identified as the acquirer (公開買付者). The report details the board's resolution to recommend the tender offer, the rationale (MBO structure, strategic investment plans, and addressing TSE Prime Market listing criteria), and the structure of the transaction, including subsequent steps like squeeze-out and stock exchanges. This structure—a target company's board expressing an opinion on a tender offer made by an acquirer—is the defining characteristic of a Tender Offer Report or a related document under Japanese financial regulations (specifically referencing the Cabinet Office Ordinance on Disclosure Concerning Tender Offer for Share Certificates, etc., by Persons Other Than the Issuer, Form No. 4). Among the provided codes, none perfectly match a 'Tender Offer Opinion Statement' (TOB Opinion Statement). However, the content is fundamentally about a takeover/merger activity. The closest fit among the provided options is 'M&A Activity' (Code: TAR), as a tender offer is a primary mechanism for M&A transactions, specifically takeovers. It is not an Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or a simple announcement of a report (RPA/RNS).
2025-05-15 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document text is extremely short (612 characters) and contains a title indicating it is related to a '第２四半期報告書' (Second Quarter Report). However, the content itself is a '確認書' (Confirmation Document) submitted to the Kanto Local Finance Bureau, confirming the appropriateness of the contents of the half-year report based on the Financial Instruments and Exchange Act. This structure—a short confirmation document accompanying or referencing a full report—strongly suggests it is an announcement or certification related to the filing, rather than the comprehensive report itself. Since it confirms the contents of a semi-annual report, the most appropriate classification among the options is 'Interim / Quarterly Report' (IR) if it were the report, but given the short length and confirmation nature, it aligns best with a regulatory filing or a specific confirmation document. Given the context of confirming a '半期報告書' (Half-Year Report), and the document being a confirmation rather than the full report, it is closely related to the IR category. However, since it is a formal confirmation document related to the filing process rather than the financial data itself, and it is very short, it could be considered a Regulatory Filing (RNS) or a specific type of confirmation. Since the core subject is the '半期報告書' (Interim Report), and this document certifies its accuracy, it is highly related to the IR filing. Given the options, and the fact that it is a formal submission confirming the accuracy of the semi-annual filing, it is a specific regulatory document. If the full report was attached, this would be RPA. Since it is a formal confirmation document related to the semi-annual filing, and it is not a standard 10-K or a general announcement, I will classify it based on the underlying report it certifies, which is the Interim Report (IR), but acknowledge its nature as a confirmation. Upon re-evaluation based on the 'MENU VS MEAL' rule: This is a short confirmation document ('確認書') about the half-year report, not the report itself. This points towards a general Regulatory Filing (RNS) or a specific confirmation. Since 'IR' is for the comprehensive report, and this is a certification, RNS is a safer fallback for a specific, short regulatory certification that doesn't fit other categories. However, the content is explicitly about the '半期報告書' (Interim Report). Let's check if there is a better fit. There is no specific code for 'Confirmation of Filing'. Given the strong link to the semi-annual period, and the document being a formal submission, I will lean towards the most relevant financial period report type, IR, but the confidence will be moderate due to the confirmation nature.
2025-05-15 Japanese
半期報告書－第21期(2024/10/01－2025/09/30)
Interim / Quarterly Report Classification · 1% confidence The document is a '第２四半期報告書' (Second Quarter Report) for MedPeer, Inc., covering the period from October 1, 2024, to March 31, 2025. It contains detailed financial statements, including the balance sheet and income statement, and is filed in accordance with the Financial Instruments and Exchange Act of Japan. As it is a comprehensive quarterly financial report containing actual financial data and analysis, it falls under the 'Interim / Quarterly Report' category. H1 2025
2025-05-15 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.